Gregory T. Hradsky Cyclacel Pharmaceuticals, Inc. (CYCC) insider trading activity

CYCC Quotes by TradingView

Gregory T. Hradsky is Director of Cyclacel Pharmaceuticals, Inc.. Currently has a direct ownership of 2,374 shares of CYCC, which is worth approximately $759. The most recent transaction as insider was on Jun 15, 2021, when has been sold 2,374 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.37K
0% 3M change
0% 12M change
Total Value Held $759

Gregory T. Hradsky Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 15 2021
BUY
Grant, award, or other acquisition
-
2,374 Added 50.0%
2,374 Common Stock
GTH

Gregory T. Hradsky

Director
Berkeley Heights, NJ

Track Institutional and Insider Activities on CYCC

Follow Cyclacel Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYCC shares.

Notify only if

Insider Trading

Get notified when an Cyclacel Pharmaceuticals, Inc. insider buys or sells CYCC shares.

Notify only if

News

Receive news related to Cyclacel Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CYCC